Sonoma Biotheraputics

Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat severe autoimmune and inflammatory diseases by restoring immune system balance. Founded by pioneers in Treg biology and cell therapy, the company leverages proprietary platform technologies and approaches to develop a new generation of targeted and durable Treg cell therapies.